Were Hedge Funds Right About Coherus Biosciences Inc (CHRS)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Charming Shoppes Inc (CHRS)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Is Coherus Biosciences Inc (CHRS) A Good Stock To Buy ?
Is Coherus Biosciences Inc (NASDAQ:CHRS) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it...
Hedge Funds Have Never Been More Bullish On Coherus Biosciences Inc (CHRS)
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies...
Hedge Funds Have Never Been This Bullish On Coherus Biosciences Inc (CHRS)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...
Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Should You Buy Coherus Biosciences Inc (CHRS)?
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
13G Filing: Partner Fund Management and Coherus Biosciences Inc. (CHRS)
You can access the original SEC filing by clicking here.
Coherus Biosciences Inc (CHRS) Could Be A Discount Entry On The Pullback
Coherus Biosciences Inc (NASDAQ:CHRS) just announced that it has kicked off a public offering that will se it unload $125 million worth of its common stock, alongside an additional grant to the underwriters...
Hedge Funds Are Betting On Coherus Biosciences Inc (CHRS)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent of AbbVie Inc (NYSE:ABBV) as requested by Coherus ...
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
